TNF and metabolic dysfunction-associated steatohepatitis: To elucidate the underlying mechanism by which infusion of Exo/ASO-TNF or Exo/2DG mitigated experimental NASH in mice, we performed RNA-seq analysis to compare hepatic mRNA profiles between mice treated with Exo/ASO-TNF or Exo/2DG and Exo control.